Australia markets closed

Lumos Pharma, Inc. (LUMO)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
7.33+0.08 (+1.10%)
At close: 04:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Cash flows from operating activities
Net income
-29,519
-30,430
-5,663
-42,989
-53,595
Depreciation & amortisation
45
203
584
1,094
1,145
Deferred income taxes
-
0
-9,500
-
-
Stock-based compensation
2,395
2,879
1,074
6,722
17,120
Change in working capital
-204
-2,314
-3,618
4,595
-2,711
Accounts payable
-
-
-
-
-13,029
Other working capital
-27,299
-29,678
-23,027
-30,207
-37,946
Other non-cash items
-
-
426
-
-
Net cash provided by operating activities
-27,269
-29,648
-22,997
-30,207
-37,939
Cash flows from investing activities
Investments in property, plant and equipment
-
-30
-30
-
-7
Sales/maturities of investments
-
-
-
-
0
Net cash used for investing activities
-30
25,970
116,649
77
117
Cash flows from financing activities
Debt repayment
-
0
-27
-61
-167
Common stock issued
-
-
-
-
0
Common stock repurchased
-
-
-
-36
-275
Other financing activities
-88
-262
-38
-
-
Net cash used provided by (used for) financing activities
-44
-192
75
-59
-148
Net change in cash
-27,343
-3,870
93,727
-30,189
-37,970
Cash at beginning of period
114,101
98,679
4,952
120,738
158,708
Cash at end of period
86,758
94,809
98,679
90,549
120,738
Free cash flow
Operating cash flow
-27,269
-29,648
-22,997
-30,207
-37,939
Capital expenditure
-
-30
-30
-
-7
Free cash flow
-27,299
-29,678
-23,027
-30,207
-37,946